Efficacy and safety of capecitabine-based first-line chemotherapy in advanced or metastatic breast cancer: a meta-analysis of randomised controlled trials. [electronic resource]
- Oncotarget Nov 2015
- 39365-72 p. digital
Publication Type: Journal Article; Meta-Analysis
1949-2553
10.18632/oncotarget.5460 doi
Antimetabolites, Antineoplastic--adverse effects Breast Neoplasms--drug therapy Capecitabine--adverse effects Disease-Free Survival Female Humans Randomized Controlled Trials as Topic Treatment Outcome